Annual Drug Patent Expirations for RECLAST
Reclast is a drug marketed by Sandoz and is included in one NDA. It is available from one supplier. There are two patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for RECLAST.
This drug has thirty-eight patent family members in twenty-eight countries.
The generic ingredient in RECLAST is zoledronic acid. One supplier is listed for this compound. Additional details are available on the zoledronic acid profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com